Effects of combinations of azaserine and of 6-diazo-5-oxo-L-norleucine with purine analogs and other antimetabolites on the growth of two mouse mammary carcinomas.
D000818:Animals; D000963:Antimetabolites; D000970:Antineoplastic Agents; D001377:Azaserine; D001940:Breast; D001943:Breast Neoplasms; D003980:Diazooxonorleucine; D006801:Humans; D007930:Leucine / Q000031:analogs & derivatives; D008325:Mammary Neoplasms, Experimental; D011687:Purines; D012694:Serine / Q000031:analogs & derivatives
D000963:Antimetabolites; D000970:Antineoplastic Agents; D011687:Purines; D003980:Diazooxonorleucine; D012694:Serine; D001377:Azaserine; D007930:Leucine
BREAST NEOPLASMS/experimental; CYTOTOXIC DRUGS; LEUCINE/related compounds; SERINE/related compounds